| Title |
|
|
|
A randomised trial to compare the effect of pre- or postoperative nandroparin on blood loss during elective caesarean section
|
|
| Author |
|
|
|
|
|
| Abstract |
|
|
|
| Objective: To compare operative blood loss following caesarean section in relation to the timing of administration of nandroparin, given to prevent perioperative deep vein thrombosis. Patients: Forty-four patients undergoing scheduled, primary elective caesarean section in full-term singleton pregnancies were included in this study. Interventions: A prospective randomised trial was performed, in which 2850 IU of nandroparin was administered either 12 h prior to or 12 h following surgery. Outcome measures: Haemoglobin and haematocrit levels, as indirect measures of blood loss, were compared in the two groups before and 2 days after surgery. Findings: Both groups were composed of 22 women. No significant differences between the outcome measures were observered. Conclusions: Nandroparin can safely be administered 12 It before planned caesarean section without significantly increasing blood loss. | |
|
| Language |
|
|
|
English
|
|
| Source (journal) |
|
|
|
Phlebology: the English language journal of the Union internationale de phlebologie / Union internationale de phlebologie. - London |
|
| Publication |
|
|
|
London : 2002
|
|
| ISSN |
|
|
|
0268-3555
|
|
| Volume/pages |
|
|
|
17:2(2002), p. 67-69
|
|
| ISI |
|
|
|
000179351100006
|
|
| Full text (Publisher's DOI) |
|
|
| |
|
| Full text (publisher's version - intranet only) |
|
|
| |
|